Search
for

    Sort by

    Research 30 of 1000+

    1. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    2. New drugs: Iobenguane sulfate Australian Prescriber · 2004
    3. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    4. New drugs: Agalsidase beta Australian Prescriber · 2004
    5. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    6. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    7. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004
    8. Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program BMJ Open Diabetes Research & Care · 2020 · 13 citations
    9. Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus Arthritis Research & Therapy · 2021 · 1 citations
    10. Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart Cardiovascular Research · 2020 · 47 citations
    11. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008 · 343 citations
    12. Metabolic risk in PCOS: phenotype and adiposity impact Trends in Endocrinology and Metabolism · 2015 · 162 citations
    13. Polycystic Ovarian Syndrome: Long-Term Health Consequences Seminars in Reproductive Medicine · 2017 · 34 citations
    14. Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes Journal of Human Nutrition and Dietetics · 2002 · 68 citations
    15. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    16. Evaluation of hyperandrogenemia and metabolic risk profile in women with postadolescent acne Turkderm · 2016
    17. A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome Women's Health · 2015 · 5 citations
    18. Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis Gynecologic and Obstetric Investigation · 2024
    19. Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer Dermatologic Surgery · 2011 · 12 citations
    20. Is early onset androgenic alopecia a marker of metabolic syndrome and carotid artery atherosclerosis in young Indian male patients? International Journal of Trichology · 2015 · 24 citations
    21. PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment Journal of Clinical Medicine · 2023 · 5 citations
    22. The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract Evidence-based Complementary and Alternative Medicine · 2016 · 8 citations
    23. Extraskeletal actions of vitamin D Annals of the New York Academy of Sciences · 2016 · 119 citations
    24. Polycystic Ovary Syndrome in Adolescents Current Women's Health Reviews · 2010
    25. RSPO1, a potent inducer of pancreatic β cell neogenesis Cell Reports Medicine · 2025 · 1 citations
    26. The Physiological Impact of Melatonin, Its Effect on the Course of Diseases and Their Therapy and the Effect of Magnetic Fields on Melatonin Secretion—Potential Common Pathways of Influence Biomolecules · 2024 · 3 citations
    27. iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice Biochemical and Biophysical Research Communications · 2018 · 3 citations
    28. Effects of Selenium and Other Micronutrient Intake on Human Health 2025
    29. Improving Rural Nurse Practitioner Knowledge About Polycystic Ovary Syndrome Through Continuing Education Journal of Continuing Education in Nursing · 2018 · 3 citations
    30. Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review Frontiers in Pharmacology · 2026